News
Videos
Conferences
Events
Resources
Subscribe

|Videos|December 1, 2020

ALK+ Metastatic Non-Small Cell Lung Cancer: The Importance of Biomarker Testing

Author(s)Jonathan W. Riess, MD, MS, UC Davis Comprehensive Cancer Center

Newsletter

Stay up to date on cancer updates, research and education

Related Content

image of two woman.

Improving End-of-Life Care: Making Hospice and Home Support Accessible

ByMaureen Canavan ,Dr. Kerin Adelson

October 22nd 2025

Image of females.

Breast Cancer Survivors Share Advice for Newly Diagnosed Patients

ByMaureen Green,Silvia Davis

October 21st 2025

Image of lungs.

Alecensa Improves 4-Year Survival in Early ALK-Positive Lung Cancer

October 20th 2025

Ivonescimab plus chemotherapy significantly improved progression-free survival versus Tevimbra advanced squamous non–small cell lung cancer.

Ivonescimab Combo Improves Progression-Free Survival in Advanced NSCLC

October 19th 2025

Image of lungs.

Sacituzumab Tirumotecan Improves Survival in EGFR-Mutated Non-Small Cell Lung Cancer

October 19th 2025

Trending on CURE

Verzenio Plus Endocrine Therapy Benefits Survival for Some With Breast Cancer

FDA Accepts Application for Padcev Plus Keytruda For Some With Bladder Cancer

Stage 1 Multiple Myeloma Treatment Options and Side Effect Management

Improving End-of-Life Care: Making Hospice and Home Support Accessible

Alternative Docetaxel Dosing Reduces Toxicity Risk in Prostate Cancer

© 2025 MJH Life Sciences^®

All rights reserved.